| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Department of Medicine, Division of Gastroenterology,
Department of Pathology, and
Greenebaum Cancer Center, School of Medicine, University of Maryland, and
Veterans Affairs Maryland Health Care System, Baltimore, MD 21201;
¶ Laboratoire de Chimie et Biochimie Pharmacologiques, Unité Mixte de Recherche 8601, Centre National de la Recherche Scientifique, Université René Descartes, Paris, France; and
|| Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, MD 21231
Arginase is the endogenous inhibitor of inducible NO synthase (iNOS), because both enzymes use the same substrate, L-arginase (Arg). Importantly, arginase synthesizes ornithine, which is metabolized by the enzyme ornithine decarboxylase (ODC) to produce polyamines. We investigated the role of these enzymes in the Citrobacter rodentium model of colitis. Arginase I, iNOS, and ODC were induced in the colon during the infection, while arginase II was not up-regulated. L-Arg supplementation of wild-type mice or iNOS deletion significantly improved colitis, and L-Arg treatment of iNOS–/– mice led to an additive improvement. There was a significant induction of IFN-
, IL-1, and TNF-
mRNA expression in colitis tissues that was markedly attenuated with L-Arg treatment or iNOS deletion. Treatment with the arginase inhibitor S-(2-boronoethyl)-L-cysteine worsened colitis in both wild-type and iNOS–/– mice. Polyamine levels were increased in colitis tissues, and were further increased by L-Arg. In addition, in vivo inhibition of ODC with -difluoromethylornithine also exacerbated the colitis. Taken together, these data indicate that arginase is protective in C. rodentium colitis by enhancing the generation of polyamines in addition to competitive inhibition of iNOS. Modulation of the balance of iNOS and arginase, and of the arginase-ODC metabolic pathway may represent a new strategy for regulating intestinal inflammation.
This article has been cited by other articles:
|
|
 |
|
  K. Miki, A. Kumar, R. Yang, M. E. Killeen, and R. L. Delude Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G840 - G848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Chaluvadi, R. D. Kinloch, B. A. Nyagode, T. A. Richardson, M. J. Raynor, M. Sherman, L. Antonovic, H. W. Strobel, D. L. Dillehay, and E. T. Morgan Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium Drug Metab. Dispos., February 1, 2009; 37(2): 366 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Gerner and F. L. Meyskens Jr. Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and Inflammation Clin. Cancer Res., February 1, 2009; 15(3): 758 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Singh, R. Chaturvedi, M. Asim, D. P. Barry, N. D. Lewis, M. P. Vitek, and K. T. Wilson The Apolipoprotein E-mimetic Peptide COG112 Inhibits the Inflammatory Response to Citrobacter rodentium in Colonic Epithelial Cells by Preventing NF-{kappa}B Activation J. Biol. Chem., June 13, 2008; 283(24): 16752 - 16761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vareille, F. Rannou, N. Thelier, A.-L. Glasser, T. de Sablet, C. Martin, and A. P. Gobert Heme Oxygenase-1 Is a Critical Regulator of Nitric Oxide Production in Enterohemorrhagic Escherichia coli-Infected Human Enterocytes J. Immunol., April 15, 2008; 180(8): 5720 - 5726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chaturvedi, M. Asim, N. D. Lewis, H. M. S. Algood, T. L. Cover, P. Y. Kim, and K. T. Wilson L-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori Infect. Immun., September 1, 2007; 75(9): 4305 - 4315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Borenshtein, P. R. Nambiar, E. B. Groff, J. G. Fox, and D. B. Schauer Development of Fatal Colitis in FVB Mice Infected with Citrobacter rodentium Infect. Immun., July 1, 2007; 75(7): 3271 - 3281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vareille, T. de Sablet, T. Hindre, C. Martin, and A. P. Gobert Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli PNAS, June 12, 2007; 104(24): 10199 - 10204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gao, X. Xu, S. Belmadani, Y. Park, Z. Tang, A. M. Feldman, W. M. Chilian, and C. Zhang TNF-{alpha} Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion Injury Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Horowitz, D. G. Binion, V. M. Nelson, Y. Kanaa, P. Javadi, Z. Lazarova, C. Andrekopoulos, B. Kalyanaraman, M. F. Otterson, and P. Rafiee Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1323 - G1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. I. Bussiere, R. Chaturvedi, M. Asim, K. L. Hoek, Y. Cheng, J. Gainor, A. Scholz, W. N. Khan, and K. T. Wilson Low Multiplicity of Infection of Helicobacter pylori Suppresses Apoptosis of B Lymphocytes. Cancer Res., July 1, 2006; 66(13): 6834 - 6842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. van Erp, K. Dach, I. Koch, J. Heesemann, and R. Hoffmann Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica Physiol Genomics, March 13, 2006; 25(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Richardson, M. Sherman, L. Antonovic, S. S. Kardar, H. W. Strobel, D. Kalman, and E. T. Morgan HEPATIC AND RENAL CYTOCHROME P450 GENE REGULATION DURING CITROBACTER RODENTIUM INFECTION IN WILD-TYPE AND TOLL-LIKE RECEPTOR 4 MUTANT MICE Drug Metab. Dispos., March 1, 2006; 34(3): 354 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Martin and J. L. Wallace Gastrointestinal Inflammation: A Central Component of Mucosal Defense and Repair Experimental Biology and Medicine, February 1, 2006; 231(2): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cheng, R. Chaturvedi, M. Asim, F. I. Bussiere, H. Xu, R. A. Casero Jr., and K. T. Wilson Helicobacter pylori-induced Macrophage Apoptosis Requires Activation of Ornithine Decarboxylase by c-Myc J. Biol. Chem., June 10, 2005; 280(23): 22492 - 22496. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
